UY31642A1 - Imidazolidina-2,4.dionas sustituidas con arilo, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos. - Google Patents

Imidazolidina-2,4.dionas sustituidas con arilo, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos.

Info

Publication number
UY31642A1
UY31642A1 UY031642A UY31642A UY31642A1 UY 31642 A1 UY31642 A1 UY 31642A1 UY 031642 A UY031642 A UY 031642A UY 31642 A UY31642 A UY 31642A UY 31642 A1 UY31642 A1 UY 31642A1
Authority
UY
Uruguay
Prior art keywords
compounds
drugs
imidazolidina
dionas
arilo
Prior art date
Application number
UY031642A
Other languages
English (en)
Inventor
Dr Irvin Winkler
Dr Matthias Gossel
Dr Siegfried Stengelin
Dr Thomas Klabunde
Dr Gerhard Jaehne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of UY31642A1 publication Critical patent/UY31642A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La invención se refiere a Imidazolidina-2,4-dionas sustituidas con arilo de la fórmula I en la que cada uno de los radicales R y R´, A, D, E, G, L, p y R1 a R10 es como se ha definido anteriormente, y a sales fisiológicamente compatibles de los mismos. Los compuestos son adecuados, por ejemplo, como fármacos antiobesidad.
UY031642A 2008-02-07 2009-02-06 Imidazolidina-2,4.dionas sustituidas con arilo, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos. UY31642A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08290130 2008-02-07

Publications (1)

Publication Number Publication Date
UY31642A1 true UY31642A1 (es) 2009-08-31

Family

ID=39493923

Family Applications (1)

Application Number Title Priority Date Filing Date
UY031642A UY31642A1 (es) 2008-02-07 2009-02-06 Imidazolidina-2,4.dionas sustituidas con arilo, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos.

Country Status (8)

Country Link
US (1) US20110053947A1 (es)
EP (1) EP2252591B1 (es)
AR (1) AR070524A1 (es)
AT (1) ATE513815T1 (es)
CL (1) CL2009000259A1 (es)
TW (1) TW200942528A (es)
UY (1) UY31642A1 (es)
WO (1) WO2009097999A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3159331A1 (en) 2010-05-05 2017-04-26 Infinity Pharmaceuticals, Inc. Tetrazolones as inhibitors of fatty acid synthase
US20130197043A1 (en) 2010-08-31 2013-08-01 Snu R&Db Foundation Use of the fetal reprogramming of a ppar agonist
US9981928B2 (en) 2013-06-20 2018-05-29 Bayer Cropscience Aktiengesellschaft Aryl sulfide derivatives and aryl sulfoxide derivatives as acaricides and insecticides
CN113024513A (zh) * 2021-03-22 2021-06-25 中国药科大学 新型雄激素受体降解剂、制备方法和医药用途
AU2022414087A1 (en) * 2021-12-14 2024-08-01 Trustees Of Tufts College Use of hyperpolarizing agents alone and in combination with other therapeutic agents for treating cancers including glioblastoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19530298C2 (de) * 1995-08-17 1999-07-22 Woerwag Pharma Gmbh Verwendung von Orotsäure zur Prävention und Therapie des metabolischen Syndroms
WO2004101529A1 (ja) * 2003-05-19 2004-11-25 Ono Pharmaceutical Co., Ltd. 含窒素複素環化合物およびその医薬用途

Also Published As

Publication number Publication date
AR070524A1 (es) 2010-04-14
EP2252591B1 (de) 2011-06-22
EP2252591A1 (de) 2010-11-24
WO2009097999A1 (de) 2009-08-13
CL2009000259A1 (es) 2009-06-26
US20110053947A1 (en) 2011-03-03
ATE513815T1 (de) 2011-07-15
TW200942528A (en) 2009-10-16

Similar Documents

Publication Publication Date Title
UY31644A1 (es) Imidazolina -2,4-dionas sustituidas, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos.
UY31651A1 (es) Nuevos derivados de fluoroglicósidos aromáticos, medicamentos que comprenden estos compuestos y uso de los mismos.
UY33458A (es) Derivados de metoxifenilo heterocíclicamente sustituidos con un grupo oxo, procedimientos para su preparación y uso de los mismos como medicamentos
CO6620050A2 (es) Derivados de aminopirimidina como moduladores de la lrrk2
ECSP13012611A (es) Derivados de pirazol-aminopirimidina como moduladores de la lrrk2
CU20120099A7 (es) Derivados de pirazina y su uso en el tratamiento de trastornos neurológicos
ECSP12012161A (es) Compuestos en calidad de antagonistas de Bradiquinina-b1
CR11861A (es) Compuestos organicos
CO6450612A2 (es) Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750
UY33541A (es) N-((6-amino-piridin-3-il)-metil)-heteroaril-carboxamidas
UY32799A (es) Derivados de oxazina y su uso en el tratamiento de trastornos neurológicos
UY33817A (es) ?nuevas oxindolpirimidinas bencílicas?.
UY33199A (es) 5-alquinil-pirimidinas.
UY32918A (es) Nuevos compuestos de 2-piridona
BR112012029647A2 (pt) novos derivados de pirimidinas
UY33205A (es) Naftiridinas sustituidas y su uso como medicamentos
UY33484A (es) Derivados de dioxido de 1,3-propano sustituidos por espirociclos, procedimientos de obtencion y uso medico
UY31645A1 (es) Nuevas imidazolidinas fenil-sustituidas, procedimiento para su preparación, medicamentos que conprenden dichos compuestos y su uso.
CO6470820A2 (es) Espiro-epóxidos como productos intermedios
UY31643A1 (es) Imidazolidina-2,4-dionas arilcalcogenoarilalquil-sustituidas, procedimiento para su preparación, medicamentos que comprenden estos compuestos y uso de las mismas
UY31287A1 (es) Antagonistas del receptore de bradiquinina b1. sus procesos de preparación y aplicaciones.
UY31642A1 (es) Imidazolidina-2,4.dionas sustituidas con arilo, procesos para su preparación, medicamentos que comprenden estos compuestos y uso de los mismos.
DOP2007000121A (es) Imidazolidina-2,4-dionas sustituidas con arilaminoarilalquilo, procedimiento para su preparación, medicamentos que comprenden estos compuestos y su uso
CR9734A (es) Derivados de 3-sulfonilindazol sustituido como ligandos de 5-hidroxitriptamina-6
UY31641A1 (es) Imidazolidin-2,4-dionas sustituidas con heterociclos, un proceso para su preparación, medicamentos que las comprenden y su uso.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130206